Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)
Stephanie M. Cushman(Duke Medical Center), Andrew B. Nixon(Duke University), Kouros Owzar(Duke University), Alan P. Venook(University of California, San Francisco), Herbert I. Hurwitz(Duke Medical Center), Donna Niedzwiecki(Duke University), Ace J. Hatch(Duke Medical Center), Ivo Shterev(Statistical and Applied Mathematical Sciences Institute), Chen Jiang, Alexander B. Sibley(Duke University)
Cited by 87
Related Papers
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|998